Introduction
Left ventricular hypertrophy (LVH), which occurs mainly in chronic left ventricular overload such as essential or secondary hypertension, is presently defined as a state of pathological growth of the left ventricle characterised by an increase in both the left ventricular mass (LVM) and the wall thickness, disturbances in the contractile function, 1 electrophysiology, 2 and coronary perfusion. 3 Athlete's heart, on the other hand, is considered as a physiological model of LVH. 4 There are some observations, that suggest that the coronary microcirculatory function is altered in pathological LVH also in the absence of an associated coronary artery disease (CAD), reflecting a reduction in the density of resistance coronary arterioles, an increase in their wall thickness/ lumen ratio, a reduction in the coronary vasodilator capacity, and an increase in the systolic difficulty of coronary flow in LVH. 5 Different methodological approaches such as nuclear PET 6, 7 and intravascular ultrasound have been used to study this problem. 8, 9 The aim of the present study of myocardial perfusion by quantitative myocardial contrast echocardiography (QMCE), 10, 11 was to analyse some functional coronary microcirculatory aspects (CM) both at rest and after vasodilator stimulus (dipyridamole) in two different models of LVH in humans: physiological (athlete's heart) and pathological (hypertensive heart).
Methods

Study population
Three groups of age-matched males (case-control study) were studied: 10 never treated and uncomplicated young adult essential arterial hypertensives in good haemodynamic compensation (Group H), 10 elite isotonic athletes (cyclists) (Group A), and 10 sedentary healthy controls (Group C).
The preliminary exclusion criteria included: malignant or accelerated hypertension, congestive heart failure, cardiomyopathy, obesity (body mass index o30 kg/m 2 ), diabetes (fasting blood glucose o6.6 mmol/1, 120 mg/dl), previous myocardial infarction, a history of renal and connective tissue disease, serum creatinine o106 mmol/l (1.2 mg/dl), the documentation of valvular heart disease by Doppler analysis, as well as the presence of clinical and instrumental (positivity of ECGstress test, performed for all subjects at maximum workload permitted for age and sex) findings of CAD. All included subjects have a normal acoustic window. Additional inclusion criteria for hypertensives were a strict age-match with other groups, as well as the athletes, and a left ventricular mass index (LVMi) within two standard deviations of the mean of the control group, according to the standardisation of M-mode measurements of the LVM.
The 10 elite athletes (cyclists) performed the following training programme: 3-4 h of daily activity for 5 days a week, consisting of bicycle endurance for 3 days and aerobic-anaerobic training for 2 days. They performed either a middle-distance race (20 km) or a long-distance race (50 km) once every 7 or 15 days.
A total of 10 aged-matched sedentary normotensive subjects without any evidence of organic disease were used as control group. The demographic features of all three groups are reported in Table 1 . The local Ethical Committee approved the study.
Experimental procedures
Both systolic (SBP) and diastolic (DBP) (Korotkoff V phase) blood pressure values were measured with the patient in supine position using a mercury sphygmomanometer at the time of the echocardiographic examination. The reported value was the mean of several indirect recordings taken over a 30-min period. 12 Ambulatory blood pressure monitoring (ABPM) was performed using an oscillometric monitor (SpaceLabs 90207, SpaceLabs) on a regular working day.
Ultrasound instrumentation
Conventional and myocardial contrast echocardiographic studies were performed with a digitised Philips Sonos 5500 echograph equipped with a broadband sector transducer (S4 fusion imaging. 2-4 MHz) and an all-digital front-end scanner and beam former.
Conventional Doppler echocardiography
LVM was calculated using Devereux's formula (Penn convention) 13 and normalised for body surface area (LVMi bs ) and for height 2.7 , LVMi h 2.7 ). The following pulsed Doppler transmitral flow velocity parameters were also evaluated: peak E; peak A; E/A ratio; mitral acceleration time (HR indexed) (mAccTc); mitral deceleration time (HR indexed) (mDecTc); isovolumic relaxation time (HR indexed) (IVRTc). All recordings were analysed on two separate occasions for intraobserver variability as well as by a blinded investigator for interobserver variability, in order to assess the reproducibility of the results. Both inter-and intraobserver variability were minimal. The correlation between measured parameters ranged from 0.92 to 0.96 for interobserver, and from 0.93 to 0.97 for intraobserver variability.
Quantitative Myocardial Contrast Echocardiography
Echocardiographic contrast agent
The echocardiographic contrast agent used in this study was Levovist (Schering AG, Berlin, Germany), a first-generation contrast agent composed of semifree air-filled microbubbles stabilised by palmitic acid in a galactose-water solution The agent was prepared 2 min before injection by suspending 4 g of the galactose microparticles in 8 ml of sterile water to obtain an effective concentration of 400 mg/ml. The activated agent contains a fairly wide size distribution of microbubbles; the bubble size predominantly ranged from 2 to 8 mm, with 97% of the bubbles being less than 6 mm upon examination using laser analysis.
Harmonic power Doppler imaging
Harmonic power Doppler (HPD) imaging is a relatively new technique for the detection of microbubbles in myocardial tissue; this technique displays the backscattered power or energy from targets interrogated by the ultrasound beam.
14 In addition, the backscattered power of the HPD signal is directly proportional to the concentration of the contrast agent, making it more amenable to quantitative analysis. We have used the background subtraction. To put differently, assuming that image signal other than the enhancement due to contrast agent is 'background' information, or noise, since only signal of interest is that due to agent, the background information is subtracted from the total signal. 15 The appearance and the disappearance of the microbubbles in the myocardial microcirculation was seen as a colour-graded variation, respectively and linearly corresponding to the increase or the decrease of Doppler energy generated by microbubbles resonance. 16 Hence, the HPD images are viewed in triggered mode every five cardiac beats so that the microbubbles have sufficient time to replenish the imaging scan plane after intermittent exposure/ destruction. The instrument settings were then held constant for the rest of the protocol.
The contrast agent, Levovist, was then injected at the same concentration and dosage, in all study subjects, with an infusion pump, into the previously prepared antecubital vein of the patient according to the following protocol: 3 ml (1200 mg) in rapid bolus (15 s) and then 1 ml (400 mg) every minute, for 8 min, using continuous pump infusion, at the same pulsing interval and until the contrast agent disappeared from the myocardium. The bolus allowed us to analyse both the left ventricle opacification and the initial myocardial perfusion until the peak intensity (appearance phase), while the continuous pump infusion is useful to study the disappearance phase. 17 The triggered image sequence was then used in cine-loop memory for the entire duration of the contrast effect, including the precontrast baseline and the postcontrast disappearance phase images. These images were then stored onto optical disc for subsequent off-line quantitative analysis.
After an interval of 5 min following the first injection of contrast, coronary hyperaemia was induced in the patient with an intravenous injection of 0.56 mg/kg of dipyridamole. After 2 min, another Levovist injection was administered (similar to the protocol described above) and the study images were acquired on optical disc as before, to evaluate any differences in the coronary flow before and after coronary vasodilatation with dipyridamole. MCE reflects the concentration of injected microbubbles within the myocardium; moreover, the relative concentration of microbubbles in different myocardial beds during steady state reflects relative capillary density or the sum of their cross-sectional area in those beds. Within a given range, microbubbles concentration and video intensity are linearly related; in this regard, particular attention was paid to setting of the machine, for not exceeding the linear range between peak video intensity and microbubbles concentration.
Data analysis
Using dedicated software, the HPD images were played back from optical disc into PC memory and the HPD signal in the various coronary beds was analysed using appropriate regions-of-interest (ROIs). Rectangular ROIs (of size 22 Â 22 pixels) were placed in the middle of the myocardium of the interventricular septum (IVS) and care was taken to exclude specular reflectors on either side of the myocardial walls. The analysis of the ROI over the entire image sequence resulted in a time-intensity curve. The peak contrast intensity for each ROI was then computed after subtracting the background intensity. For the specific characteristic of the ultrasonic contrast agent (first generation) and for the type of protocol used (single end-systolic pulsing interval every five cycles, bolus+continuous infusion), we observed, despite the constant infusion of contrast agent after the bolus injection, a slow decay of peak intensity (PI) level; therefore, a time-intensity curve was then created, according to a polynomial fit, which showed the entire process of contrast agent infusion. 'Appearance' and 'disappearance' area under curve were then 'indexed' for, LVMi, to normalise the distribution of microbubbles with respect to the higher LVM of athletes and hypertensives in comparison with controls. This methodological approach allows us to speculate only about the times during the transit curves of microbubbles (Levovist) across the myocardium (in the ascending limb: the time from the appearance of contrast to (PI) relative peak effect intensity contrast (TP), and in decaying limb: the half-time (HT), which is the time between the relative peak effect intensity contrast and the subsequent half-peak intensity points). We also considered the appearance or disappearance areas under curves in absolute or indexed values (by LVMi), referring exclusively to the variation in the time of myocardial blood volume in an ROI placed in the myocardium (appearance and disappearance phases were sampled at 2/3 of time interval between peak and subsequent 2/3 intensity points) (Figures 1  and 2 ).
Both inter-and intraobserver variability of measurements were minimal. The correlation between measured parameters ranged from 0.89 to 0.94 for interobserver, and from 0.90 to 0.95 for intraobserver variability.
Statistical analysis
Continuous variables were expressed as mean 7 1s.d. Multiple group comparison was performed by analysis of variance followed by Scheffe's test. Intragroup differences were evaluated using Student's t-test. To evaluate the reliability of the contrast echocardiographic method, we applied the analysis of variance for repeated measurements, according to Bland and Altman procedures, 18 obtaining the intraclass correlation coefficient (r i ). Correlation coefficients were calculated according to the standard methods for univariate regression analysis. A P-value of o0.05 was considered statistically significant.
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Results
The demographic and clinical data relating to the three examined groups are shown in Table 1 2 ), where it is significantly higher than in C (101 7 12 g/m 2 ) (Po0.005) ( Table 1) . Athletes and hypertensives show a higher EDD in comparison with controls with a normal fractional shortening and ejection fraction. Hypertensives carried a modest impairment of the global left ventricular diastolic function, showing a significantly higher end-diastolic transmitral flow velocity (peak A) and E/A ratio ( Table 1) . The other diastolic functional parameters such as mAcctc, mDecTc, and IVRTc also overlapped in the three groups.
Myocardial contrast echocardiography
Dipyridamole induced different responses in the three groups. The per cent increase of HR after dipyridamole was significantly higher in athletes (+50%) in comparison with hypertensive individuals and controls (+28%) (Po0.05). Hypertensives showed a higher heart rate-pressure product both at rest and at peak of stress in comparison with both athletes and controls ( Table 2 ). The PI was significantly higher in athletes than in hypertensives and controls, both at rest and after dipyridamole. The Coronary microcirculation and contrast echocardiography V Di Bello et al per cent increase of PI after dipyridamole was significantly higher in C (+73%, Po0.01) than in H (+31%) and in A (+33%) (Po0.05). The appearance area both in absolute and indexed values was significantly lower in H in comparison with C and A, both at rest and after vasodilatation (Tables 3 and 4 ). The disappearance area at rest, both in absolute and in indexed value, was comparable in both groups C and H and significantly higher in A. Its per cent increase after dipyridamole was nevertheless significantly higher in C and in A (+124%) than in H (+104%) (Po0.05).
Time to peak was significantly lower in hypertensive patients than in athletes and controls both at rest and after dipyridamole. HT was significantly higher in H and in A vs C, both at rest and after dipyridamole (Po0.01) ( Table 4 ). Significant relations were found between at-rest PI and LVMi (r ¼ 0.57, Po0.001), and between basal disappearance area and LVMi (r ¼ 0.48; Po0.01).
Discussion
The present study has demonstrated that the two LVH models, despite the comparable LVM, showed substantial differences when compared with healthy controls and among themselves in the behaviour of QMCE parameters, which indirectly reflect the coronary microcirculatory function, in particular as variation of myocardial blood volume, analysed before and after the vasodilator stimulus.
The main point was the significantly higher basal relative PI in A in comparison with H. This behaviour was observed also after vasodilatation with dipyridamole and it was a signal of a Coronary microcirculation and contrast echocardiography V Di Bello et al significantly higher microbubbles distribution in A than in H. This happened despite the superimposable LVMi in both groups (A and H). An increase in the LVM, where the relation between capillary bed distribution and hypertrophied myocardium (rarefaction phenomenon) was not completely respected, was observed in hypertensive patients. In athletes on the other hand, at a higher LVMi, it seems to correspond to a proportioned distribution of myocardial capillary bed (angiogenesis).
Coronary flow regulation and reserve
The regulation of the myocardial blood flow in humans is a complex phenomenon dependent on coronary perfusion pressure and/or vasomotor changes in epicardial conduit vessels, the function of coronary microcirculation and extravascular forces, particularly intramyocardial pressure. 19 Some intracoronary imaging devices 20 have allowed the measurement of the pressures and the analysis of the anatomy and function of the epicardial conduit vessels; furthermore, the visualisation of the coronary microcirculation, so far performed only in experimental animal preparations, has been made possible. 21, 22 The basic concept was to quantify the ability of the coronary microvasculature to dilate and the vasodilator reserve is expressed as the ratio of 'maximal' to baseline blood flow. In practice, to achieve coronary vasodilation, intravenous adeno- Coronary microcirculation and contrast echocardiography V Di Bello et al sine or dipyridamole 23, 24 was used in most of the published studies; the degree of coronary dilatation achievable with these drugs in humans seems to be comparable to that obtained with intracoronary papaverine. 25, 26 In the present study, dipyridamole was used as a vasoactive agent to test coronary microcirculatory function. Dipyridamole increases interstitial adenosine concentration in vascular smooth muscle cells and determines a relaxation of coronary resistance vessels. The coronary flow response as assessed by intravenous dipyridamole infusion is therefore most likely to reflect the combined effect of vascular smooth muscle relaxation and endothelial-mediated vasodilatory function and can be used as an integrating measure of coronary reactivity. 27, 28 
Previous studies with other methodologies
By applying the argon method in order to examine the correlation between myocardial hypertrophy and myocardial blood flow, Vogt et al 29 were able to assess the global blood flow in basal conditions and during maximal vasodilatation, and to calculate the vascular resistance and coronary flow reserve for the entire heart. No significant correlation between flow data and echocardiographically assessed LVMi was found. Houghton et al 30 found no linear relation between flow reserve and the degree of left ventricular hypertrophy when using Doppler catheterderived coronary flow measurements. This showed that hypertensive patients who displayed thallium 201 perfusion defects had a significantly lower coronary flow reserve and higher LVMi in comparison with patients with negative scans. Using PET, Gimelli et al 31 confirmed that the left ventricular mass is not correlated to global MBF. The study proved that patients affected by LVH showed a heterogeneous flow pattern with regional defects, and almost normal blood flow in nonaffected regions. Another comment on the above-mentioned case study was that during stress the myocardial blood flow frequently shows a diffuse reduction in hypertensive patients with a homogeneous pattern. Through the use of PET, Laine et al 6 observed a reduced coronary reactivity in young asymptomatic men presenting borderline hypertension and no signs of hypertension-induced angina or LVH. As baseline basal myocardial blood flow was unchanged, the reduction in coronary flow reserve may depend on an impaired maximal vasodilator capacity. In studies carried out using intravascular Doppler technology, Hamasaki et al 9 concluded that LVH in hypertension could induce a vascular remodelling and an impairment of both the endothelium-dependent and -independent vasomotion responses.
Coronary microcirculation in pathological and physiological LVH
In the present study, the coronary microcirculation explored with QMCE in hypertensive subjects showed a different behaviour when compared with athletes and controls:
* The appearance area, also LVMi indexed, was significantly lower in hypertensives in comparison both with athletes and controls because of a significantly lower time to peak. A lower number of microbubbles could therefore reach the coronary microcirculation in the myocardium in a shorter time, despite the increase in the LVM. This phenomenon could be explained by an increase in the coronary vascular resistance in hypertensives. * The reached PI at rest was significantly lower in controls in comparison with hypertensives. The increase in the PI value after vasodilatation induced by dipyridamole is higher in controls (+73%) than in hypertensives (+31%) and in athletes (+33%) (Po0.05). This finding could be determined by a lower response to dipyridamole in hypertensives, through the endothelium vasodilatation mechanisms activated by the increase of shear stress owing to flow augmentation after dipyridamole infusion, while in athletes, the circulatory system could be partially activated (vasodilatation) through other metabolic or ionic mechanisms. There is a significant linear relation between PI and LVMi even if only in basal condition, which linked the higher LVMi in hypertensives and the absolute value of PI in both groups (as expression of a higher number of microbubbles in a hypertrophied myocardium).
The dipyridamole infusion introduced many other variables in the system, which are possibly responsible for a loss of significance of the relation between the previous parameters. * The disappearance area, both for absolute and indexed values, was significantly higher in athletes at rest and after dipyridamole in comparison with both hypertensives and controls; the per cent increase after dipyridamole infusion was comparable in the three groups. The disappearance area, LVMi indexed, was comparable in both groups at rest and after the administration of dipyridamole. The increase of this parameter induced by dipyridamole was nevertheless significantly higher in controls (+124%) and in athletes 107.5%) than in hypertensives (+90%, Po0.05), thus confirming that in healthy controls and in athletes, the vasodilatation action induced by dipyridamole is higher than in hypertensives, allowing a higher persistence of microbubbles in the capillary bed.
Some experimental and human studies realised with different methodologies have shown nonuniform results in this field of research, so that several hypothesis could be made. In particular, in hypertensives' heart disease, the pressure-volume overload means a burden to the ventricle as well as to the coronary vessels, which has several potential consequences for the coronary microcirculation: (a) resistance vessels, capillaries, perivascular interstitium, and myocytes are liable to suffer damage by hypoperfusion; (b) arterial vascular walls are under increased shear and wall stress (dysfunctional endothelial function with inadequate nitric oxide production), 32 (c) hypertrophy of the myocytes leads to an increase in the distance between parallel oriented arterioles and capillaries (relative rarefaction). 5, 6 In addition, several other extravascular mechanisms can contribute to the impairment of coronary vasodilator reserve in hypertensives; these include: the negative effect of impaired diastolic relaxation on coronary filling, the compression of the coronary circulation by high left ventricular filling pressure and relative increased force of contraction. An impairment of the arteriolar vasodilatation response to dipyridamole/adenosine was observed in hypertensive patient. This was revealed by a significantly lower time to peak in comparison with controls, as expression of an increased arteriolar resistance to flow and a related lower wash-in area (LVMi indexed) in comparison with healthy controls. It was also seen as expression of a lower number of microbubbles distributed in the myocardial capillary bed. In hypertensive subjects, these findings could be probably combined with both a potentially reduced endothelium function and the capillaries rarefaction, as underlined by the reduced per cent increase of PI and of disappearance area (LVMi indexed), which is seen in hypertensives in comparison with healthy subjects after a vasodilator stimulus with dipyridamole. Furthermore, in hypertensives, the percentage hyperaemic flow increase after dipyridamole is diminished as a result of the increased baseline blood flow in LVH of essential arterial hypertension.
Another explanation of these findings could be because of the mere effect that baseline myocardial blood flow in hypertension is increased in comparison with normotensive individuals and that (as maximum blood flow is not affected) the coronary vasodilatory reserve after dipyridamole is less in hypertensive subjects (as outlined by Hoffmann 33, 34 ). On the other hand, aerobic exercise training induces an increase in coronary blood flow capacity that is associated with an adjusted control of coronary vascular resistance and, as a consequence, coronary blood flow. 35 Most data indicate that training results in an enhanced response of coronary arteries to endothelium-mediated vasodilatation. 36 It is possible that these changes result from an increase in the nitric oxide synthesis pathway for inducing vasodilatation by the endothelium of coronary arteries. 37 Training increases resistance vessel sensitivity or maximal responsiveness to adenosine. 38 Exercise training has also been shown to induce alterations in the cellular-molecular control of intracellular Ca 2+ in coronary vascular smooth muscle of conduit coronary arteries, and to enhance myogenic reactivity of coronary resistance arteries. 39 The structural vascular remodelling that happens in response to exercise training occurs in two forms: increase in the cross-sectional area of the proximal coronary arteries and angiogenesis; angiogenesis has been demonstrated in that training causes moderate cardiac hypertrophy while maintaining or increasing capillary and arteriolar density. The hypothesis that the coronary microcirculation in athletes could be characterised by a new greater distribution of capillaries, proportioned to the physiological LVH (angiogenesis), which is activated by training, can be put forward. This functional behaviour of microcirculation could be explained also by a parallel higher nitric oxide synthesis from the endothelium of the coronary vessels (owing to shear stress increase 40 ), which allows the dilation and the availability of these new capillary ways. A further confirmation of these mechanisms was the significant linear relation between at-rest PI and LVMi and hence a higher number of microbubbles are detected in the athlete's heart myocardium. By increasing interstitial adenosine release, the vasodilation induced by dipyridamole determines a further increase in the microbubbles number in the capillary bed in both athletes and controls, as shown by the increase in PI and of the wash-out area after a dipyridamole injection. Interstitial adenosine functionally induces a vasodilation both with a reduction in the coronary artery resistance and with a stimulus to produce nitric oxide by the endothelium of coronary circulation.
Limitations of the study
The main strength of this study lies in the recruitment of subjects of the same sex, with a closely comparable cardiac mass and age, as well as a selection procedure (in particular, never treated and uncomplicated young adult hypertensives) that excluded important confounding factors (case-control selection). However, the study has limitations as well. The motion of the heart is a tricky problem. Even though the trigger goes off at end-systole every five beats, because of the cardiac translation and rotation and patient respiration, it cannot be guaranteed that researchers are looking at the same scan plane of the heart when they compare pre-and postvasodilatation images. With our method and using a first-generation ultrasonic contrast agent, we do not observe a steady-state concentration of microbubbles within the coronary circulation and it is not possible to measure the replenishment of microbubbles into coronary microcirculation; 41 for these reasons it is not possible to calculate coronary blood flow velocity and volume, such as from the myocardial refilling curves, which can be obtained using second-generation ultrasonic contrast agent.
Conclusion
The QMCE approach could represent one way to analyse some behaviours of coronary microcirculation in a noninvasive and available approach; furthermore, QMCE in the present study allowed us to evidentiate that some differences exist in coronary microcirculatory functional behaviour between athletes and hypertensives with comparable LVM. A real-time perfusion ultrasonic imaging with second-generation contrast agent will be helpful, with the application of adequate algorithms, for the analysis of MCE images, for a better definition of the microbubbles kinetic through the myocardial capillary system
